United Therapeutics (UTHR)
United Therapeutics (UTHR) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- UTHR last traded at $554.73 on 2026-11-20, -0.78% for the session.
- United Therapeutics: market cap $23.63B, P/E 19.2, revenue $3.19B over the last four quarters.
- Over the past year UTHR returned 16.41%, with a year-to-date return of 13.85%.